The worldwide market for automated external defibrillator (AED) is expected to grow at a CAGR of 5.4 percent over the next 5 years, reaching USD 930 million in 2024, from USD 680 million in 2019, estimates Market Watch.
The implantable cardioverter defibrillator (ICD) segment accounted for the largest share in the global market. The transvenous and subcutaneos ICDs are expected to exhibit the fastest growth rate in the global market. The overall ICD segment contributes for the largest market share, owing to the rising integration of multiple technological capabilities in a single device, such as defibrillators and pacemakers.
With rising prevalence of cardiovascular diseases and advancement in the medical technology, North America is expected to dominate this market. Companies that are contributing in the automated external defibrillator market are: Laerdal Medical, Nihon Kohden, Mediana, Philips, Metrax GmbH, Schiller, Beijing MandB Electronic, A.M.I. Italia, Defibtech, HeartSine Technologies, Physio-Control, Instramed, Cardiac Science, METsis Medikal, Shenzhen XFT, Zoll, and Mindray.